Quick links

Secure login

Secure file transfer protocol

Register or renew user

Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944

Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Provider agreement form

On behalf of patients

Request or update record
Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

New Vaccine Products Available Through VFC & VFAAR

05 Jan New Vaccine Products Available Through VFC & VFAAR

Posted at 16:42h in Flu, VFAAR, VFC by

New Vaccine Products Available Through VFC & VFAAR

View more information about Priorix and Vaxneuvance, now available through VFC and VFAAR, below. There have been a number of updates to the available vaccines for the VFC and VFAAR programs. Lists of vaccines currently available through VFC and VFAAR can be accessed through these links.

Complete the following survey to notify our program of which vaccine your site prefers. We will review each site’s submission and reach out with next steps. We recommend that sites that are part of a system or are affiliated use the same vaccine presentations across sites to ensure continuity of care and help prevent administration errors.

Vaccine Change Request

Priorix and Vaxneuvance

In line with the updated ACIP recommendations:

Priorix (Measles, Mumps and Rubella, MMR) is now available through the Vaccines Children (VFC) and Vaccines for Adults at Risk (VFAAR) programs.

  • Priorix is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.
  • For all recommendations, MMR II and Priorix can be used interchangeably.
  • VFC and VFAAR providers must decide whether they will order MMR II or Priorix going forward. To change the product your site orders, complete the Vaccine Change Request form, linked above.
  • CVX code: 03 CPT code: 90707
  • For more information on Priorix, review the summary document.

Vaxneuvance (15-valent pneumococcal conjugate vaccine, PCV15) is now available through the VFC program.

  • Vaxneuvance is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 2 months of age and older.
  • For all recommendations, PCV13 and PCV15 can be used interchangeably.
  • VFC providers must decide whether they will order Prevnar (PCV13) or Vaxneuvance (PCV15) going forward going forward. To change the product your site orders, complete the Vaccine Change Request form, linked above.
  • CVX code: 215
  • CPT code: 90671
  • For more information on Vaxneuvance, review the summary document.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.